Get started
Author

Conor M.W. Douglas

Observed names: Conor Douglas, Conor M. W. Douglas, Conor MW Douglas
Observed institutions: University of British Columbia, York University, Rathenau Instituut, Amsterdam Public Health, University of York, University of Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam
ORCID: 0000-0002-3302-1743
Observed ORCID: 0000-0002-3302-1743
OpenAlex ID: A5103178696
Why orphan drug coverage reimbursement decision-making needs patient and public involvement
2015 · Conor M.W. Douglas, Elizabeth Wilcox, et al. · Health Policy · 48
Challenges for the European governance of synthetic biology for human health
2014 · Conor MW Douglas, Dirk Stemerding · Life Sciences Society and Policy · 36
PDF
Making Sense of Medicines: ‘Lay Pharmacology’ and Narratives of Safety and Efficacy
2009 · Andrew Webster, Conor Douglas, et al. · Science as Culture · 36
Governing synthetic biology for global health through responsible research and innovation
2013 · Conor M. W. Douglas, Dirk Stemerding · Systems and Synthetic Biology · 29
PDF
Evaluating Canadians’ Values for Drug Coverage Decision Making
2018 · Shirin Rizzardo, Nick Bansback, et al. · Value in Health · 27
PDF
Governing the research-care divide in clinical biobanking: Dutch perspectives
2015 · Martin Boeckhout, Conor M.W. Douglas · Life Sciences Society and Policy · 17
PDF
Governing biological material at the intersection of care and research: the use of dried blood spots for biobanking
2012 · Conor M.W. Douglas, Carla G. van El, et al. · Croatian Medical Journal · 16
PDF
Socio-Cultural characteristics of usability of bioinformatics databases and tools
2011 · Conor Douglas, Rebecca Goulding, et al. · Interdisciplinary Science Reviews · 11
The Politics of Representation in the Governance of Emergent 'Secondary Use' Biobanks: The Case of Dried Blood Spot Cards in the Netherlands
2012 · Conor Douglas, Carla van El, et al. · Studies in Ethics Law and Technology · 10
Mothers' Views on Longer Storage of Neonatal Dried Blood Spots for Specific Secondary Uses
2015 · Sarah R. van Teeffelen, Conor M.W. Douglas, et al. · Public Health Genomics · 8
Rethinking biobanking and translational medicine in the Netherlands: how the research process stands to matter for patient care
2014 · Conor MW Douglas, Philip Scheltens · European Journal of Human Genetics · 8
Special issue editorial: synthetic biology, global health, and its global governance
2013 · Conor M. W. Douglas, Dirk Stemerding · Systems and Synthetic Biology · 4
PDF
Methodology for constructing scenarios for health policy research: The case of coverage decision-making for drugs for rare diseases in Canada
2021 · Conor M.W. Douglas, Dimitra Panagiotoglou, et al. · Technological Forecasting and Social Change · 3
Scientific Literacy and Public Understandings of Science
2017 · Conor M.W. Douglas · The Blackwell Encyclopedia of Sociology · 1
BSE in the United Kingdom
2009 · Andrew Webster, Conor M.W. Douglas, et al. · Alliance for Global Sustainability bookseries · 1
Davis, C. and Abraham, J.Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science. Basingstoke: Palgrave Macmillan. 2013. 336pp £65.00 (hbk) ISBN: 978–0‐230–00866–3
2014 · Conor M. W. Douglas · Sociology of Health & Illness
Book Review: Alex Faulkner: Medical Technology into Healthcare and Society: A Sociology of Devices, Innovation and Governance.
2012 · Conor M.W. Douglas · Pure Amsterdam UMC
Reflections on Dr. Olga Amsterdamska
2010 · Chunglin Kwa, Conor Douglas · Science Technology & Human Values
Emergence of Asbestos-related Health Issues and Development of Regulatory Policy in the UK
2009 · Andrew Webster, Conor M. W. Douglas, et al. · Alliance for Global Sustainability bookseries
Synthetic Biology for Human Health: Ethical and Legal Issues
2007 · F.W.A. Brom, Conor M.W. Douglas, et al.
Report on the Tenth Colloquium of the Postgraduate Forum on Genetics and Society (PFGS)
2006 · Conor Douglas · Genomics Society and Policy
PDF
Works count: 21
Citation count: 255
H-index: 9
I10-index: 9
Year
Topic
Type